
4.3/5
133 Ratings , 29 Reviews
Transformative Strategies for Neonatal Abstinence Syndrome
Price:$99.99
According to 2020 data from the Healthcare Cost and Utilization Project (HCUP), which is managed by the U.S. Agency for Healthcare Research and Quality, about six newborns were diagnosed with neonatal abstinence syndrome (NAS) for every 1,000 newborn hospital stays. That is approximately one baby diagnosed with NAS every 24 minutes in the United States, or more than 59 newborns diagnosed every day. The number of babies born with NASincreased by 82% nationally from 2010 to 2017. Increases were seen for nearly all states and demographic groups (Centers for Disease Control and Prevention, 2023). NeonatalIntensive Care Units (NICUs) across the country are looking to best support this growing population to manage the symptoms and engage families. This course will review the etiological process of NAS, understand the symptoms of the disease process, and provide practical evidence-based strategies for rehab therapists working in the NICU to implement immediately at the conclusion of this course.
The content of this program is germane to children, students and clients preterm-3months.
Target Audience: Physical Therapists, Physical Therapist Assistants, Occupational Therapists, Occupational Therapy Assistants, Speech-Language Pathologists
3/5
Janae (CA) on Feb 14, 2026
it was difficult to follow the instructor, she did not sound professional and said 'i'm' several times every sentence. it greatly impacted the material for me. some material seemed very subjective, versus clinical.
4/5
Lindsay (CO) on Feb 09, 2026
great instructor!
4/5
Kendyll (TX) on Jan 26, 2026
instructor says "umm" way too much
4/5
Angela (OH) on Jan 04, 2026
some of the info seemed very basic for clinicians who have been practicing with neonatals for a bit.
4/5
Christine (CA) on Jan 01, 2026
the way the information about gestational age was presented made it sound as though younger gestational age might be protective against the effects of substance exposure. my understanding, however, is that substance exposure early in pregnancyparticularly opiatescan negatively impact both brain and somatic growth. this may include decreased brain volumes (cerebellar, cerebral, and basal ganglia), as well as iugr, sga, and low birth weight, all of which can contribute to ongoing neurodevelopmental delays, especially the behavioral and sensory challenges that often become more apparent in school-aged children. the literature suggests that prenatal substance exposure can affect fetal growth and neurodevelopment across gestation, with timing influencing the type of impact rather than the presence or absence of risk. it may be helpful to clarify that while infants exposed in the third trimester can show more pronounced withdrawal symptoms due to placental thinning, exposure in any trimester can affect fetal growth and neurodevelopment through different mechanisms, including structural brain changes, impaired growth trajectories, and later behavioral or cognitive outcomes.
5/5
Jane (IN) on Dec 05, 2025
i really liked the short and long term goal examples. also the q %26a at the end was helpful as these were questions that i also had and was looking for future ces to answer.
5/5
Deborah (FL) on Nov 24, 2025
would like a part 2 with more detailed info on drug interaction in the brain
4/5
Kristen (AK) on Oct 10, 2025
slow paced, but fine overall and very applicable topic and information for therapists that work with infants and older with history of exposure and working with parents and caregivers
5/5
Irene (TX) on Jul 31, 2025
great resourses
5/5
Rosana (CA) on Jul 23, 2025
i liked the case examples and specific goals and treatment ideas.
THE npte podcast

THE npte podcast
Your go-to source for expert tips, exam strategy, and motivation — all hosted by Dr. Crane.
Listen Now
PT & OT Connection Podcast

PT & OT Connection Podcast
Tune in for engaging discussions on important topics to you and your patients.
Listen Now
Copyright © 2026 Summit Professional Education, LLC. All Rights Reserved. | Privacy Policy | Subscription Terms | Summit W-9